GRCE
NASDAQ · Pharmaceuticals
Grace Therapeutics Inc
$2.38
+0.16 (+7.21%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+870.2% upside
Low Target
$18.68
Average Target
$23.09
High Target
$33.94
Current Price
$2.38
Current
$2.38
$2.38
Target
$23.09
$23.09
$18.68
$23.09 avg
$33.94
Scenario Analysis
Bear Case
$18.68
684.9%
Low target
Base Case
$23.09
+870.2%
Avg target
Bull Case
$33.94
+1,326.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$5.18
-54.1% from high
52-Week Low
$1.79
+33.0% from low
Target vs 52W High
$23.09
+345.8% vs high
Peer Consensus — Pharmaceuticals